SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007462
Filing Date
2022-05-06
Accepted
2022-05-05 17:41:33
Documents
89
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q akya-20220331x10q.htm   iXBRL 10-Q 1808955
2 EX-31.1 akya-20220331xex31d1.htm EX-31.1 14844
3 EX-31.2 akya-20220331xex31d2.htm EX-31.2 14901
4 EX-32.1 akya-20220331xex32d1.htm EX-32.1 6806
5 EX-32.2 akya-20220331xex32d2.htm EX-32.2 7822
  Complete submission text file 0001558370-22-007462.txt   8337820

Data Files

Seq Description Document Type Size
6 EX-101.SCH akya-20220331.xsd EX-101.SCH 55606
7 EX-101.CAL akya-20220331_cal.xml EX-101.CAL 67213
8 EX-101.DEF akya-20220331_def.xml EX-101.DEF 248404
9 EX-101.LAB akya-20220331_lab.xml EX-101.LAB 507329
10 EX-101.PRE akya-20220331_pre.xml EX-101.PRE 422250
83 EXTRACTED XBRL INSTANCE DOCUMENT akya-20220331x10q_htm.xml XML 1507753
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40344 | Film No.: 22897975
SIC: 3826 Laboratory Analytical Instruments